Anatrace Revenue and Competitors

Maumee, OH USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Anatrace's estimated annual revenue is currently $1.7M per year.(i)
  • Anatrace's estimated revenue per employee is $155,000

Employee Data

  • Anatrace has 11 Employees.(i)
  • Anatrace grew their employee count by -15% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$1.7M110%N/AN/A
#3
$0.8M50%N/AN/A
#4
$5.1M3314%N/AN/A
#5
$64.6M4172%N/AN/A
#6
$1.7M11-8%N/AN/A
#7
$0.8M50%N/AN/A
#8
$7.4M48-41%N/AN/A
#9
$0.6M40%N/AN/A
#10
$0.9M1220%N/AN/A
Add Company

What Is Anatrace?

Research facilities, academic institutions and industrial customers worldwide have trusted Anatrace for high-purity detergents, lipids, customs and, of course, higher standards since the late 1980's. Once again a privately owned business, we’re now setting those standards higher than ever before. Well regarded as top performers for membrane protein structural biology, Anatrace products are chosen for their uniquely pure molecules – and the exacting chemistry behind them. From compounds designed to disrupt cell membranes to products that stabilize or solubilize unstable macromolecules and proteins, we’re always raising the bar. So your structural studies, functional biology work, or chemical synthesis project will yield incredibly reliable results. Along with our vast portfolio of products, our chemists can develop specialized solutions tailored to meet your unique specifications. We can also provide custom synthesis services and expert analytical work to aid your own research and development team. The possibilities are limitless – just like the levels of perfection we reach for.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.1M17-19%N/A
#2
$1.1M180%N/A
#3
$5.2M2117%N/A
#4
$4.9M26-37%N/A
#5
$6M26-4%N/A